Health Economics of Antibiotics by Steven Simoens

Subjects: Get full text

Cost Utility Analysis of Multidisciplinary Postacute Care for Stroke: A Prospective Six-Hospital Cohort Study by Yu-Ching Chen, Yu-Ching Chen, Yu-Jo Yeh, Chung-Yuan Wang, Chung-Yuan Wang, Hsiu-Fen Lin, Hsiu-Fen Lin, Ching-Huang Lin, Hong-Hsi Hsien, Kuo-Wei Hung, Jung-Der Wang, Hon-Yi Shi, Hon-Yi Shi, Hon-Yi Shi, Hon-Yi Shi

Subjects: Get full text

Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? – a cost-utility analysis by Gary M. Ginsberg, Eli Somekh, Yechiel Schlesinger

Subjects: “…Cost-utility analysis…”
Get full text

[Nintedanib for the treatment of idiopathic pulmonary fibrosis in Italy] by Andrea Belisari, Daria Bettoni, Paolo Angelo Cortesi, Lucia Sara D'Angiolella, Lorenzo Giovanni Mantovani, Gerardo Miceli Sopo, Marino Nonis

Subjects: Get full text

Considering the societal perspective in economic evaluations: a systematic review in the case of depression by Juliane Andrea Duevel, Lena Hasemann, Luz María Peña-Longobardo, Beatriz Rodríguez-Sánchez, Isaac Aranda-Reneo, Juan Oliva-Moreno, Julio López-Bastida, Wolfgang Greiner

Subjects: “…Cost-utility analysis…”
Get full text

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis by Saharat Aungsumart, Saowalak Turongkaravee, Sitaporn Youngkong, Metha Apiwattanakul, Ammarin Thakkinstian, Usa Chaikledkaew

Subjects: Get full text

Cost-utility Analysis of the EOX Drug Regimen versus the DCF Drug Regimen for Patients with Advanced Gastric Cancer by Mohammad Javad Khezeli, Mehdi Dehghani, Khosro Keshavarz, Zahra Kavosi

Subjects: “…Cost-utility…”
Get full text

Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure by Praveen Thokala, Baalbaki Hassan, Pandor Abdullah, John W. Stevens, Brennan Alan

Subjects: “…cost-utility analysis…”
Get full text

Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China by Jia Liu, Jia Liu, Lidan Cao, Lidan Cao, Jing Wu, Jing Wu

Subjects: “…cost-utility…”
Get full text

Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia by Anthony J. Hatswell, Gwilym J. Thompson, Penny A. Maroudas, Oleg Sofrygin, Thomas E. Delea

Subjects: Get full text

Cost-utility analysis of genomic profiling in early breast cancer in Colombia by Leonardo Rojas, María X. Rojas-Reyes, Diego Rosselli, Juan Guillermo Ariza, Alejandro Ruiz-Patiño, Andrés F. Cardona

Subjects: Get full text

Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure by Praveen Thokala, Baalbaki Hassan, Pandor Abdullah, John W. Stevens, Brennan Alan

Subjects: “…cost-utility analysis…”
Get full text

Markov Models for Economic Evaluation in Osteoporosis Treatment by Marta Osca-Guadalajara, Javier Díaz-Carnicero, Silvia González-de-Julián, David Vivas-Consuelo

Subjects: Get full text

Corrigendum: Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China by Jia Liu, Jia Liu, Lidan Cao, Lidan Cao, Jing Wu, Jing Wu

Subjects: “…cost-utility…”
Get full text

A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas by Michele Basile, Ilaria Valentini, Roberto Attanasio, Renato Cozzi, Agnese Persichetti, Irene Samperi, Alessandro Scoppola, Renata Simona Auriemma, Ernesto De Menis, Felice Esposito, Emanuele Ferrante, Giuseppe Iatì, Diego Mazzatenta, Maurizio Poggi, Roberta Rudà, Fabio Tortora, Fabio Cruciani, Zuzana Mitrova, Rosella Saulle, Simona Vecchi, Paolo Cappabianca, Agostino Paoletta, Alessandro Bozzao, Marco Caputo, Francesco Doglietto, Francesco Ferraù, Andrea Gerardo Lania, Stefano Laureti, Stefano Lello, Davide Locatelli, Pietro Maffei, Giuseppe Minniti, Alessandro Peri, Chiara Ruini, Fabio Settanni, Antonio Silvani, Nadia Veronese, Franco Grimaldi, Enrico Papini, Americo Cicchetti

Subjects: Get full text

Cost-Utility Analysis of Open Hernia Operations in Bulgaria by Kirilova-Doneva M., Kamusheva M., Gerasimov N., Petrova G.

Subjects: “…cost-utility analysis…”
Get full text

Economic Evaluation of Cataract: A Systematic Mapping Review by José Ginel, Noemi Burguera, Carlos Rocha-de-Lossada, David Piñero, Alejandro Sáez-Martín, Joaquín Fernández

Subjects: Get full text

Budget impact and cost-utility analysis of prophylactic emicizumab versus on-demand bypassing agents for adolescent severe haemophilia A patients with inhibitors in India by Yuvaraj Krishnamoorthy, Dhanajayan Govindan, Narasimhapriyan Kannan, Marie Gilbert Majella, Vishnu Shankar Hariharan, Vivek Valliappan

Subjects: “…Cost utility analysis…”
Get full text

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study by Torre E, Bruno GM, Di Matteo S, Martinotti C, Valentino MC, Bottaro LC, Colombo GL

Subjects: Get full text

[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy] by Elena Galli, Maria Paola Pedone, Miryana Dobreva, Rossella Bitonti, Roberta Di Turi

Subjects: Get full text